Person

Nicholas Donoghoe

EVP, CHIEF BUS/STRAT OFFICER, AbbVie

Current S&P 500 boards
0
Current roles
1
Open-market buys
$498K
Open-market sales
$15.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • ABBV
    AbbVie
    EVP, CHIEF BUS/STRAT OFFICER
    since Jan 2019

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 14, 2026ABBVSale32,710$250.00$8.2M
Aug 5, 2025ABBVSale10,061$198.59$2.0M
Aug 5, 2025ABBVSale3,234$198.27$641K
Mar 20, 2024ABBVSale21,082$176.30$3.7M
Dec 26, 2023ABBVSale2,912$154.72$451K
Aug 29, 2019ABBVBuy7,525$66.19$498K

SEC reporting-owner ID (CIK) 1762951 · all filings on EDGAR

Nicholas Donoghoe (ABBV) | USBoard